- In a press conference, the official said that Jadhav insisted on the mercy petition he filed on April 17, 2017.
- As per Pakistan media reports, Pakistan government has offered second consular access to Jadhav, who was sentenced to death by a
Pakistani military court on charges of "espionage and terrorism" in April 2017. - Following the development, India approached the International Court of Justice (ICJ) against Pakistan for denial of consular access to Jadhav and challenging the death sentence.
Pakistan has claimed that captured Indian national
"On June 17, 2020, Indian national Kulbhushan Jadhav was invited to file a petition for review and reconsideration of his sentence and conviction. Exercising his legal right he refused to file a petition for review and reconsideration of his sentence and conviction," Pakistan Additional Attorney General Ahmed Irfan claimed on Wednesday.
In a press conference, the official said that Jadhav insisted on the mercy petition he filed on April 17, 2017.
As per Pakistan media reports, Pakistan government has offered second consular access to Jadhav, who was sentenced to death by a Pakistani military court on charges of "espionage and terrorism" in April 2017.
Following the development, India approached the International Court of Justice (ICJ) against Pakistan for denial of consular access to Jadhav and challenging the death sentence.
In May this year, Pakistan had said that it has "fully compiled" with the ICJ's judgement in Jadhav case, days after India's lead counsel asserted that New Delhi had hoped it might be able to persuade Islamabad through "back channel" to release the Indian death-row convict.
Senior advocate
Jadhav, in his 50s, is a retired
In July 2019, the ICJ ordered Pakistan not to execute Jadhav and asked it to reconsider the death sentence awarded to him by a military court.
SEE ALSO:
INTERVIEW: Shaaz Jung opens up about the blood, sweat and years behind the viral images of a rare black panther
Coronavirus herd immunity may be 'unachievable' after study suggests antibodies disappear after weeks in some people